Market Overview

UPDATE: ISI Group Initiates CVS Caremark at Overweight, $53.50 PT

Share:
Related CVS
New York City Bans Tobacco Sales In Pharmacies; Will Walgreens Follow CVS's Lead And Exit This Category?
Mid-Afternoon Market Update: Michael Kors Gains On Earnings Beat; Commercial Vehicle Shares Slide
Sterling Capital Management LLC Buys HCA Healthcare Inc, McKesson Corp, Dollar General Corp, ... (GuruFocus)

ISI Group initiated its coverage on CVS Caremark (NYSE: CVS) with a rating of Overweight and a price target of $53.50.

ISI Group commented, "Our thesis for CVS is based on our view of continued share gain at the pharmacy given the success of Maintenance Choice and the continuation of the WAG/ESRX dispute, improved growth and profitability at Caremark as a result of innovative solutions and the streamlining initiative, and a very shareholder friendly approach to capital deployment and enhanced capital returns."

CVS Caremark closed at $46.90 on Wednesday.

Latest Ratings for CVS

DateFirmActionFromTo
Aug 2017CitigroupMaintainsNeutral
Aug 2017Wolfe ResearchDowngradesOutperformPeer Perform
Jun 2017NeedhamInitiates Coverage OnHold

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (CVS)

View Comments and Join the Discussion!